Literature DB >> 30005737

Heart rate variability in individuals with Down syndrome - A systematic review and meta-analysis.

Tatiana Dias de Carvalho1, Thais Massetti2, Talita Dias da Silva3, Tânia Brusque Crocetta4, Regiani Guarnieri4, Luiz Carlos Marques Vanderlei5, Carlos Bandeira de Mello Monteiro2, David M Garner6, Celso Ferreira3.   

Abstract

INTRODUCTION: Down syndrome (DS) results in many changes, including dysfunction in cardiac autonomic modulation. Heart rate variability (HRV) analysis evaluates the autonomic function and it is a predictor of adverse cardiovascular events.
OBJECTIVE: To present results of a systematic review and a meta-analysis about heart rate variability in individuals with DS.
METHOD: A systematic review was performed on PubMed, PubMed Central and Web of science databases. We included articles that exhibited all the terms: "Down Syndrome", "heart rate variability", "autonomic nervous system", "autonomic dysfunction" and "cardiac autonomic modulation". We conducted the meta-analysis to compare "DS" to "controls" during rest. Random effects models were used, as were appropriate tests for heterogeneity.
RESULTS: From 271 studies, 13 were included in our review. These are conducted with volunteers from a wide age range, of either gender, and not taking medications. Meta-analysis displayed that there were no significant differences between the groups at rest, except the RMSSD, which revealed a significant (Z = -2.80, p = 0.005) main effect (Hedge's g = -0.55, 95% CI [-0.93; -0.16]), indicating difference in individuals with DS compared with controls.
CONCLUSION: There is autonomic dysfunction in individuals with DS, which may or may not be expressed at rest, but it is usually demonstrated in an autonomic task. Meta-analysis specified that there was no significant alteration between DS and the controls during rest, except RMSSD index which was lower in DS than controls. PROSPERO: CRD42017068647.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  “Autonomic nervous system”; “Cardiac autonomic modulation”; “Down syndrome”; “Meta-analysis”; “Systematic review”

Mesh:

Year:  2018        PMID: 30005737     DOI: 10.1016/j.autneu.2018.05.006

Source DB:  PubMed          Journal:  Auton Neurosci        ISSN: 1566-0702            Impact factor:   3.145


  6 in total

1.  Children with Down syndrome and sleep disordered breathing have altered cardiovascular control.

Authors:  Rosemary S C Horne; Ashwini Sakthiakumaran; Ahmad Bassam; Julie Thacker; Lisa M Walter; Margot J Davey; Gillian M Nixon
Journal:  Pediatr Res       Date:  2020-11-23       Impact factor: 3.756

2.  Cardiac autonomic modulation in children with severe liver disease, before and after liver transplantation.

Authors:  Renata Salatini; Joice Amaral; Rodrigo Daminello Raimundo; Fernando Rocha; Luiz Carlos de Abreu; Mauro Morais; Uenis Tannuri; Ana Cristina Tannuri
Journal:  Transl Pediatr       Date:  2022-04

3.  Noninvasive assessment of autonomic modulation of heart rate variability in the Ts65Dn mouse model of Down syndrome: A proof of principle study.

Authors:  Adriano L Roque; Mark W Johnson; Melissa R Stasko; Luiz C de Abreu; Talita D da Silva; Alberto C S Costa
Journal:  Physiol Rep       Date:  2020-06

Review 4.  Adults with Down syndrome challenge another paradigm: When aging no longer entails arterial hypertension.

Authors:  Emilia Roy-Vallejo; José María Galván-Román; Fernando Moldenhauer; Diego Real de Asúa
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-07-09       Impact factor: 3.738

5.  Heart rate and blood pressure in male Ts65Dn mice: a model to investigate cardiovascular responses in Down syndrome.

Authors:  Lara R DeRuisseau; Candace N Receno; Kevin S Heffernan; Caitlin M Cunningham
Journal:  Physiol Rep       Date:  2019-09

6.  Autism risk in neonatal intensive care unit patients associated with novel heart rate patterns.

Authors:  Kaitlin R Blackard; Katy N Krahn; Robert T Andris; Douglas E Lake; Karen D Fairchild
Journal:  Pediatr Res       Date:  2021-02-18       Impact factor: 3.756

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.